Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma-Reference-Cited by-同舟云学术

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma

Published:2018-04-27 Issue:32 Volume:9 Page:22665-22679
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Stafman Laura L.¹,Mruthyunjayappa Smitha²,Waters Alicia M.¹,Garner Evan F.¹,Aye Jamie M.³,Stewart Jerry E.¹,Yoon Karina J.⁴,Whelan Kimberly³,Mroczek-Musulman Elizabeth²,Beierle Elizabeth A.¹

Affiliation:

1. Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA

2. Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA

3. Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA

4. Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIM Kinase Inhibition Sensitizes Neuroblastoma to Doxorubicin;Journal of Pediatric Surgery;2024-07

2. PIM3 Kinase: A Promising Novel Target in Solid Cancers;Cancers;2024-01-26

3. Imparting aromaticity to 2-pyridone derivatives by O -alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-01-17

4. PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma;International Journal of Molecular Sciences;2023-12-28

5. Precision Oncology in Pediatric Cancer Surgery;Surgical Oncology Clinics of North America;2023-12